Company: CERO
Filing Date: 2025-08-22
Form Type: 424B3
Source: 0001213900-25-080011
Chunk: 100

Company: CERO THERAPEUTICS HOLDINGS, INC.
Filing Date: 2025-08-22
Form: 424B3
Chunk 100
---
 Exchange Act, and our failure to timely file such reports may have material adverse consequences on our business.

Following the consummation
of the Business Combination, we failed to timely file our Form 8-K with Form 10 information prior to the “staleness” date
(as determined in accordance with the applicable rules and regulations of the SEC) applicable to the financial statements that were required
by the applicable accounting requirements and other rules and regulations of the SEC to be included in such filing (including pro forma
financial information); thus, we have not remained timely in our reporting requirements with the SEC since we became an SEC reporting
company on February 14, 2024. Although we regained status as a current filer by filing a Form 8-K/A with current financial statements
on April 1, 2024, we were unable to remain timely in our reporting requirements as a result of our failure to file this Quarterly Report
on Form 10-Q by August 19, 2025, the extended deadline resulting from our filing of a notice on Form 12b-25 on August 15, 2025, as a result,
we will not be eligible to file any new registration statement on Form S-3 and, following any requirement to amend any existing registration
statement on Form S-3, including as a result of the updating of such registration statement pursuant to Section 10(a)(3) of the Securities
Act upon the filing of our Annual Report on Form 10-K for the fiscal year ending December 31, 2025, we will not be eligible to use any
existing registration statement on Form S-3, in each case, that would allow us to continuously incorporate by reference our SEC reports
into the registration statement, or to use “shelf” registration statements to conduct offerings, until approximately one year
from the date we regained (and maintain) status as a current and timely filer. Until such time, if we determine to pursue an offering,
we would be required to conduct the offering on an exempt basis, such as in accordance with Rule 144A, or file a registration statement
on Form S-1. Using a Form S-1 registration statement for a public offering would likely take significantly longer than using a registration
statement on Form S-3 and increase our transaction costs, and could, to the extent we are not able to conduct offerings using alternative
methods, adversely impact our liquidity, ability to raise capital or complete acquisitions in a timely manner. The use of